Achieving Self Sufficiency In Data Collection For Optinose

Optinose, a specialty pharmaceutical company, sought to enhance its electronic data capture (EDC) capabilities and find a versatile and user-friendly EDC system for in-house use. To achieve this, they collaborated with Crucial Data Solutions (CDS) and implemented their TrialKit platform. Optinose's data manager received comprehensive training from CDS and successfully designed and managed their study using TrialKit. The adaptable and intuitive nature of TrialKit empowered Optinose to make multiple modifications to the study database independently, eliminating the need for third-party assistance.

This newfound self-sufficiency enabled Optinose to establish a true partnership with CDS and realize substantial value within their allocated budget. By leveraging TrialKit, unearth how Optinose has gained greater control over its EDC environment and has harnessed the potential of clinical trial technology to optimize its research processes.